News for 'dermatology'

Sun Pharma US generics biz remains under pressure

Sun Pharma US generics biz remains under pressure

Rediff.com23 May 2026

Sun Pharmaceutical Industries reported strong consolidated numbers for Q4 FY26, with net profit rising 26 per cent year-on-year to 2,714 crore, despite continued weakness in its US generics business. Growth in innovative medicines and increased R&D investments are helping to offset these pressures.

Resident Doctor Found Dead in Beed, Investigation Underway

Resident Doctor Found Dead in Beed, Investigation Underway

Rediff.com6 Apr 2026

A resident doctor at a medical college in Beed, Maharashtra, was found dead in his rented accommodation, with police investigating potential causes including work-related stress and personal issues.

Sun Pharma's Organon deal: Strategic entry into new segments, but integration challenges loom

Sun Pharma's Organon deal: Strategic entry into new segments, but integration challenges loom

Rediff.com5 May 2026

Sun Pharmaceutical Industries' acquisition of US-based Organon & Co. for $11.75 billion, the largest overseas acquisition by an Indian pharma company, has been met with mixed reactions from brokerages, who see strategic entry into women's health and biosimilars but also flag potential integration challenges and debt concerns.

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Rediff.com9 Apr 2026

India's domestic pharmaceutical market recorded its highest value growth in five quarters during Q4 FY26, driven primarily by pricing and an early indication of volume recovery, with a significant structural shift towards chronic and sub-chronic therapies.

Prolonged Sanitary Pad Use Linked to Vaginal Issues: Experts Suggest Moringa Infusion

Prolonged Sanitary Pad Use Linked to Vaginal Issues: Experts Suggest Moringa Infusion

Rediff.com17 Mar 2026

Experts warn that prolonged use of sanitary pads, especially in humid climates, can disrupt the vaginal microbiome, leading to bacterial vaginosis. Moringa-infused pads may offer a solution due to their anti-inflammatory and antimicrobial properties.

5 Ways To Build The Essential Men's Skincare Routine:

5 Ways To Build The Essential Men's Skincare Routine:

Rediff.com19 Nov 2025

Everyone's skin is different, varying between dry, oily, normal, sensitive or a mix. Men's skin is quite different from women's and needs its own regimen.

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com19 Jan 2026

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

Google readies plans for AI push in healthcare, agriculture

Google readies plans for AI push in healthcare, agriculture

Rediff.com16 Dec 2025

Google on Tuesday announced funding support of USD 8 million to India's AI Centers of Excellence for health, agriculture, education, and sustainable cities, and committed USD 4,00,000 to support development of India's health foundation model.

When To Discard Your Bra, Briefs, Body Lotions...

When To Discard Your Bra, Briefs, Body Lotions...

Rediff.com15 Dec 2025

Is there an expiry date for a bra or briefs? When do they cease to give support?

5 Natural Ways To Tighten Skin After Losing Weight

5 Natural Ways To Tighten Skin After Losing Weight

Rediff.com18 Nov 2025

Dehydration is the number one cause of saggy, dull and lifeless skin. Make sure to drink at least 12 to 13 glasses of water a day to keep your skin supple and improve its structure.

What You Must Know About Your Beard!

What You Must Know About Your Beard!

Rediff.com21 Nov 2025

'Stop touching your beard all the time. Your hands carry bacteria that can trigger acne and irritation.'

Are Your Gel Nails Secretly Ageing You?

Are Your Gel Nails Secretly Ageing You?

Rediff.com22 Oct 2025

'Gel nails look nice but your nails might not thank you for it later,' says Dr Rinky Kapoor, celebrity dermatologist and co-founder and director of The Esthetic Clinics. 'Think of nails as an investment. They're not just for beauty, they're a reflection of your overall health.'

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

'7,000 More MBBS Seats, 3,000 For PG'

'7,000 More MBBS Seats, 3,000 For PG'

Rediff.com17 Feb 2025

India is trying to add 75,000 medical seats in five years as it also eyes to touch the WHO standard of one doctor for every 1,000 persons.

How To Prevent Skin Damage This Diwali

How To Prevent Skin Damage This Diwali

Rediff.com1 Nov 2024

Going to bed without removing your makeup can clog your pores and make your complexion lacklustre, cautions Dr Trupti D Agarwal.

Weak Q4 may be rare bitter pill for Sun Pharma

Weak Q4 may be rare bitter pill for Sun Pharma

Rediff.com31 May 2024

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

Robust FY25 outlook to sustain Marico gains

Robust FY25 outlook to sustain Marico gains

Rediff.com19 Jul 2024

From its recent lows, the stock of consumer major Marico is up 7 per cent on the back of a better-than-expected June quarter performance and robust outlook. In a pre-quarter update, the management indicated that domestic volume growth should witness an improvement in FY25, while other segments (growth portfolio, international business) too would see traction going ahead. The near-term trigger is strong sales and operating performance for Q1FY25.

10 Tips To Take Care Of Your Skin This Monsoon

10 Tips To Take Care Of Your Skin This Monsoon

Rediff.com4 Jul 2024

Dr Ipshita Johri explains how you can keep your skin healthy in the rainy season.

9 Lies Told About Skincare

9 Lies Told About Skincare

Rediff.com9 Feb 2023

There seems to be a barrage of age-old blunders that people tend to commit in the name of skincare, says dermatologist Dr Batul Patel, director, The Bombay Skin Clinic.

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Rediff.com13 Nov 2023

Bolstered by an impressive performance in the global specialty business and outstanding results in the Indian market, Sun Pharmaceutical Industries, the largest pharmaceutical (pharma) company in the country, showcased a strong performance in the July-September quarter (second quarter, or Q2) of 2023-24 (FY24).

Air Pollution: How to Stay Safe

Air Pollution: How to Stay Safe

Rediff.com13 Nov 2023

Don't ignore symptoms like coughing, wheezing or shortness of breath, warns Dr Sandeep Tilve.

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

Rediff.com3 Apr 2023

India's largest listed pharmaceutical (pharma) company - Sun Pharmaceutical Industries (Sun Pharma) - is expected to maintain its outperformance vis--vis the sector's, as its multiple bets on specialty products, improving product mix, recent acquisitions, and branded business are finding favour with brokerages. While it has gained 7 per cent over the past year, the Nifty Pharma Index is down 13.6 per cent. Its outperformance over two years has been fairly evident, with the market leader gaining 66 per cent to Nifty Pharma's minus 1.4 per cent.

IISc to build 800-bed hospital with its single largest private donation

IISc to build 800-bed hospital with its single largest private donation

Rediff.com15 Feb 2022

The academic centrepiece of this initiative will be an integrated dual degree MD-PhD programme aimed at creating a new breed of physician-scientists, who will pursue careers in clinical research to develop new treatments and healthcare solutions, driven by a bench-to-bedside philosophy, a statement said.

Experts raise alarm after first monkeypox death, lay stress on surveillance

Experts raise alarm after first monkeypox death, lay stress on surveillance

Rediff.com2 Aug 2022

After confirmation of the first monkeypox death in the country by the National Institute of Virology, health experts advised strengthening the surveillance to avoid silent transmission of monkeypox.

10 Reasons You May Be Losing Hair

10 Reasons You May Be Losing Hair

Rediff.com29 Mar 2023

Deficiencies in iron, protein and zinc can particularly lead to hair fall, warns dermatologist Dr Abhishek Pilani.

After April shock, drug sales improve in May

After April shock, drug sales improve in May

Rediff.com20 May 2020

The industry feels two factors have played a role in improving the offtake and reducing trade inventory - one is that the supply chain in pharmaceuticals has more or less stabilised, and secondly, with lockdown curbs easing and OPDs opening, some demand has grown at the consumer end as well.

10 Tips To Protect Your Skin From Humidity

10 Tips To Protect Your Skin From Humidity

Rediff.com30 Aug 2022

Don't let humidity be your skin's enemy, says Dr Abhishek Pilani.

10 Haircare Mistakes To Avoid

10 Haircare Mistakes To Avoid

Rediff.com31 Oct 2022

Dust, dirt, and excess oils can clog scalp pores, causing hair loss or delayed growth, warns Dr Abhishek Pilani.

5 Tips To DETOX Your Skin

5 Tips To DETOX Your Skin

Rediff.com10 Dec 2021

Arthi Raghuram, founder of Deyga Organics shares simple tips to keep your skin healthy.

My Father, Mallikarjun Kharge

My Father, Mallikarjun Kharge

Rediff.com7 Nov 2022

'What he says, he does.' 'People say if Khargesahab has said something, it will be set in stone.'

Dr.Reddy's buys US firm Trigenesis

Dr.Reddy's buys US firm Trigenesis

Rediff.com6 May 2004

Dr.Reddy's Laboratories has acquired Trigenesis Therapeutics Inc, a United States based privately owned dermatology company, with a total investment outlay of $11 million.

As monkeypox cases rise overseas, govt issues do's and don'ts

As monkeypox cases rise overseas, govt issues do's and don'ts

Rediff.com31 May 2022

Amid increasing cases of monkeypox being reported in non-endemic countries, the government on Tuesday issued guidelines directing district surveillance units to consider even one such case as an outbreak and initiating a detailed investigation through the Integrated Disease Surveillance Programme.

Google announces new privacy settings, AI tools

Google announces new privacy settings, AI tools

Rediff.com19 May 2021

Google has announced a slew of new features including new privacy settings, AI tools and release of the first beta of Android 12 that will become part of its products over the course of the year. Kicking off Google I/O 2021 in a virtual format from the Mountain View campus, Google CEO Sundar Pichai also announced additions to Google Workspace that will enable richer collaboration, especially in view of the pandemic that has driven enterprises across the globe to embrace remote working solutions. Pichai said that COVID-19 has deeply affected every community over the past year, and "places like Brazil, and my home country of India, are now going through their most difficult moments yet".

How to fight bad body odour

How to fight bad body odour

Rediff.com1 May 2014

When excessive sweating becomes embarrassing

Biden fractures foot while playing with his dog

Biden fractures foot while playing with his dog

Rediff.com30 Nov 2020

The US president-elect twisted his ankle on Saturday when he slipped while playing with Major, one of his two German shepherd.

Big pharmas' mega plan to beat competition in US

Big pharmas' mega plan to beat competition in US

Rediff.com20 Feb 2017

Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.

Glenmark readies to enter one more niche segment in US

Glenmark readies to enter one more niche segment in US

Rediff.com29 Jan 2013

Prodded by patent cliff & increasing competition, it files application for foray into injectible oncology segment.

Sun Pharma to acquire US-based DUSA for $230 million

Sun Pharma to acquire US-based DUSA for $230 million

Rediff.com8 Nov 2012

DUSA is a dermatology company focused on developing and marketing its Levulan photodynamic therapy platform.

Medical entrance exam for MD, MS, PG diploma

Medical entrance exam for MD, MS, PG diploma

Rediff.com17 Mar 2010

Amrita School of Medicine invites applications for Amrita Entrance Examination -- Medical (2010) for admission to MD/ MS and PG diploma courses.